Daniel Raynor - Net Worth and Insider Trading
Daniel Raynor Net Worth
The estimated net worth of Daniel Raynor is at least $17 Million dollars as of 2024-09-23. Daniel Raynor is the Director of ANI Pharmaceuticals Inc and owns about 289,003 shares of ANI Pharmaceuticals Inc (ANIP) stock worth over $17 Million. Details can be seen in Daniel Raynor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel Raynor has not made any transactions after 2018-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel Raynor
Daniel Raynor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Raynor owns 2 companies in total, including ANI Pharmaceuticals Inc (ANIP) , and EQM Technologies & Energy Inc (EQTE) .
Click here to see the complete history of Daniel Raynor’s form 4 insider trades.
Insider Ownership Summary of Daniel Raynor
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ANIP | ANI Pharmaceuticals Inc | 2018-03-19 | director |
EQTE | EQM Technologies & Energy Inc | 2013-11-12 | 10 percent owner |
Daniel Raynor Latest Holdings Summary
Daniel Raynor currently owns a total of 1 stock. Daniel Raynor owns 289,003 shares of ANI Pharmaceuticals Inc (ANIP) as of March 19, 2018, with a value of $17 Million.
Latest Holdings of Daniel Raynor
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ANIP | ANI Pharmaceuticals Inc | 2018-03-19 | 289,003 | 60.06 | 17,357,520 |
Holding Weightings of Daniel Raynor
Daniel Raynor Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Raynor has made a total of 0 transactions in ANI Pharmaceuticals Inc (ANIP) over the past 5 years. The most-recent trade in ANI Pharmaceuticals Inc is the sale of 7,215 shares on March 19, 2018, which brought Daniel Raynor around $439,033.
Insider Trading History of Daniel Raynor
- 1
Daniel Raynor Trading Performance
Daniel Raynor Ownership Network
Daniel Raynor Owned Company Details
What does ANI Pharmaceuticals Inc do?
Who are the key executives at ANI Pharmaceuticals Inc?
Daniel Raynor is the director of ANI Pharmaceuticals Inc. Other key executives at ANI Pharmaceuticals Inc include SR. VP & GENERAL COUNSEL & SEC. Meredith Cook , director & HEAD OF R&D & COO-NOVITIUM OPS Muthusamy Shanmugam , and SVP - CORP. DEV. & STRATEGY Chad Gassert .
ANI Pharmaceuticals Inc (ANIP) Insider Trades Summary
Over the past 18 months, Daniel Raynor made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 776,190 shares made by Muthusamy Shanmugam , a net sale of 2,750 shares made by Meredith Cook , and a net sale of 200,000 shares made by Chad Gassert .
In summary, during the past 3 months, insiders sold 70,750 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 70,750 shares. During the past 18 months, 1,411,012 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,411,012 shares.
ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.
ANI Pharmaceuticals Inc Insider Transactions
Daniel Raynor Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Raynor. Currently GuruFocus does not have mailing address information for Daniel Raynor.